Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

Author： Guarneri Valentina  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.122, Iss.1, 2010-07, pp. : 181-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Osteonecrosis of the jaw and bevacizumab therapy

By Poznak Catherine  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 189-191

Springer Publishing Company

Access to resources Recommend Favorite

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

By Coleman R.  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 429-438

Springer Publishing Company

Access to resources Recommend Favorite

The Phenomenon of Osteonecrosis of the Jaw in Patients with Metastatic Breast Cancer

By Poznak Catherine  

Cancer Investigation, Vol. 24, Iss. 1, 2006-03 ,pp. : 110-112

Informa Healthcare

Access to resources Recommend Favorite

Bisphosphonate Therapy for Patients with Breast Cancer

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 3, 2005-01 ,pp. : 217-225

Bentham Science Publishers

Access to resources Recommend Favorite

Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis

By Walter Christian   Grötz Knut   Kunkel Martin   Al-Nawas Bilal  

Supportive Care in Cancer, Vol. 15, Iss. 2, 2007-02 ,pp. : 197-202

Springer Publishing Company

Access to resources Recommend Favorite